Accretion Pharmaceuticals Ltd

NSE: ACCPL · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹185.30
Market cap: ₹206.0 Cr
Revenue (annual): ₹89.63 Cr
Net profit (annual): ₹9.67 Cr
P/E (TTM): 21.3×Sector 47.4×
Promoter holding: 73.52%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Annual General Meeting 3 Financial Results 2 Results Correction 1 Management Change 1 Earnings Call 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

1 May 2026 19:59 IST NSE

Board Meeting Date

Accretion Pharmaceuticals Board Meeting Date

Accretion Pharmaceuticals Limited has scheduled a Board Meeting for May 8, 2026, to consider and approve its audited standalone financial results for the year ended March 31, 2026. Consequently, the trading window for designated persons has been closed from April 1, 2026.

Read the filing ↗